Signalling pathways that mediate skeletal muscle hypertrophy and atrophy (original) (raw)

• Jagoe, R.T. & Goldberg, A.L. What do we really know about the ubiquitin-proteasome pathway in muscle atrophy? Curr. Opin. Clin. Nutr. Metab. Care 4, 183–190 (2001).
  Article CAS Google Scholar
• Mosoni, L. et al. Lower recovery of muscle protein lost during starvation in old rats despite a stimulation of protein synthesis. Am. J. Physiol. Endocrinol. Metab. 277, E608–616 (1999).
  Article CAS Google Scholar
• Musaro, A. et al. Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nature Genet. 27, 195–200 (2001).
  Article CAS Google Scholar
• Mitch, W.E. & Goldberg, A.L. Mechanisms of muscle wasting — the role of the ubiquitin-proteasome pathway. N. Engl. J. Med. 335, 1897–1905 (1996).
  Article CAS Google Scholar
• Tawa, N.E. Jr, Odessey, R. & Goldberg, A.L. Inhibitors of the proteasome reduce the accelerated proteolysis in atrophying rat skeletal muscles. J. Clin. Invest. 100, 197–203 (1997).
  Article CAS Google Scholar
• Goldspink, D.F., Garlick, P.J. & McNurlan, M.A. Protein turnover measured in vivo and in vitro in muscles undergoing compensatory growth and subsequent denervation atrophy. Biochem. J. 210, 89–98 (1983).
  Article CAS Google Scholar
• DeVol, D.L., Rotwein, P., Sadow, J.L., Novakofski, J. & Bechtel, P.J. Activation of insulin-like growth factor gene expression during work-induced skeletal muscle growth. Am. J. Physiol. 259, E89–E95 (1990).
  CAS PubMed Google Scholar
• Coleman, M.E. et al. Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofibre hypertrophy in transgenic mice. J. Biol. Chem. 270, 12109–12116 (1995).
  Article CAS Google Scholar
• Musaro, A., McCullagh, K.J., Naya, F.J., Olson, E.N. & Rosenthal, N. IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1. Nature 400, 581–585 (1999).
  Article CAS Google Scholar
• Semsarian, C. et al. Skeletal muscle hypertrophy is mediated by a calcium-dependent calcineurin signalling pathway. Nature 400, 576–581 (1999).
  Article CAS Google Scholar
• Dunn, S.E., Burns, J.L. & Michel, R.N. Calcineurin is required for skeletal muscle hypertrophy. J. Biol. Chem. 274, 21908–21912 (1999).
  Article CAS Google Scholar
• Bodine, S.C. et al. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nature Cell Biol. 3, 1014–1019 (2001).
  Article CAS Google Scholar
• Rommel, C. et al. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nature Cell Biol. 3, 1009–1013 (2001).
  Article CAS Google Scholar
• Horsley, V. & Pavlath, G.K. Nfat: ubiquitous regulator of cell differentiation and adaptation. J. Cell Biol. 156, 771–774 (2002).
  Article CAS Google Scholar
• Molkentin, J.D. et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93, 215–228 (1998).
  Article CAS Google Scholar
• Serrano, A.L. et al. Calcineurin controls nerve activity-dependent specification of slow skeletal muscle fibres but not muscle growth. Proc. Natl Acad. Sci. USA 98, 13108–13113 (2001).
  Article CAS Google Scholar
• Dupont-Versteegden, E.E., Knox, M., Gurley, C.M., Houle, J.D. & Peterson, C.A. Maintenance of muscle mass is not dependent on the calcineurin–NFAT pathway. Am. J. Physiol. Cell Physiol. 282, C1387–C1395 (2002).
  Article CAS Google Scholar
• Naya, F.J. et al. Stimulation of slow skeletal muscle fibre gene expression by calcineurin in vivo. J. Biol. Chem. 275, 4545–4548 (2000).
  Article CAS Google Scholar
• Dunn, S.E., Chin, E.R. & Michel, R.N. Matching of calcineurin activity to upstream effectors is critical for skeletal muscle fibre growth. J. Cell Biol. 151, 663–672 (2000).
  Article CAS Google Scholar
• Murgia, M. et al. Ras is involved in nerve-activity-dependent regulation of muscle genes. Nature Cell Biol. 2, 142–147 (2000).
  Article CAS Google Scholar
• Vivanco, I. & Sawyers, C.L. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nature Rev. Cancer 2, 489–501 (2002).
  Article CAS Google Scholar
• Takahashi, A. et al. Myogenic Akt signalling regulates blood vessel recruitment during myofibre growth. Mol. Cell Biol. 22, 4803–4814 (2002).
  Article CAS Google Scholar
• Pallafacchina, G., Calabria, E., Serrano, A.L., Kalhovde, J.M. & Schiaffino, S. A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fibre type specification. Proc. Natl Acad. Sci. USA 99, 9213–9218 (2002).
  Article CAS Google Scholar
• Chen, W.S. et al. Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev. 15, 2203–2208 (2001).
  Article CAS Google Scholar
• Cho, H. et al. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB β). Science 292, 1728–1731 (2001).
  Article CAS Google Scholar
• Stambolic, V. et al. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95, 29–39 (1998).
  Article CAS Google Scholar
• Goberdhan, D.C., Paricio, N., Goodman, E.C., Mlodzik, M. & Wilson, C. Drosophila tumor suppressor PTEN controls cell size and number by antagonizing the Chico/PI3-kinase signalling pathway. Genes Dev. 13, 3244–3258 (1999).
  Article CAS Google Scholar
• Huang, H. et al. PTEN affects cell size, cell proliferation and apoptosis during Drosophila eye development. Development 126, 5365–5372 (1999).
  CAS PubMed Google Scholar
• Wada, T. et al. Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5′-phosphatase catalytic activity. Mol. Cell. Biol. 21, 1633–1646 (2001).
  Article CAS Google Scholar
• Stiles, B. et al. Essential role of Akt-1/Protein kinase Bα in PTEN-controlled tumorigenesis. Mol. Cell. Biol. 22, 3842–3851 (2002).
  Article CAS Google Scholar
• Clement, S. et al. The lipid phosphatase SHIP2 controls insulin sensitivity. Nature 409, 92–97 (2001).
  Article CAS Google Scholar
• Leevers, S.J., Weinkove, D., MacDougall, L.K., Hafen, E. & Waterfield, M.D. The Drosophila phosphoinositide 3-kinase Dp110 promotes cell growth. EMBO J. 15, 6584–6594 (1996).
  Article CAS Google Scholar
• Zhang, H., Stallock, J.P., Ng, J.C., Reinhard, C. & Neufeld, T.P. Regulation of cellular growth by the Drosophila target of rapamycin dTOR. Genes Dev. 14, 2712–2724 (2000).
  Article CAS Google Scholar
• Montagne, J. et al. Drosophila S6 kinase: a regulator of cell size. Science 285, 2126–2129 (1999).
  Article CAS Google Scholar
• Pullen, N. et al. Phosphorylation and activation of p70s6k by PDK1. Science 279, 707–710 (1998).
  Article CAS Google Scholar
• Nave, B.T., Ouwens, M., Withers, D.J., Alessi, D.R. & Shepherd, P.R. Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation. Biochem. J. 344, 427–431 (1999).
  Article CAS Google Scholar
• Scott, P.H., Brunn, G.J., Kohn, A.D., Roth, R.A. and Lawrence J.C. Jr Evidence of insulin-stimulated phosphorylation and activation of the mammalian target of rapamycin mediated by a protein kinase B signaling pathway. Proc. Natl Acad. Sci. USA 95, 7772–7777 (1998).
  Article CAS Google Scholar
• Reynolds, T.H.t., Bodine, S.C. & Lawrence, J.C. Jr. Control of Ser 2448 phosphorylation in the mammalian target of rapamycin by insulin and skeletal muscle load. J. Biol. Chem. 277, 17657–17662 (2002).
  Article CAS Google Scholar
• Inoki, K., Li, Y., Zhu, T., Wu, J. & Guan, K.L. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nature Cell Biol. 4, 648–657 (2002).
  Article CAS Google Scholar
• Tee, A.R. et al. Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling. Proc. Natl Acad. Sci. USA 99, 13571–13576 (2002).
  Article CAS Google Scholar
• von Manteuffel, S.R., Gingras, A.C., Ming, X.F., Sonenberg, N. & Thomas, G. 4E-BP1 phosphorylation is mediated by the FRAP-p70s6k pathway and is independent of mitogen-activated protein kinase. Proc. Natl Acad. Sci. USA 93, 4076–4080 (1996).
  Article CAS Google Scholar
• Hara, K. et al. Regulation of eIF-4E BP1 phosphorylation by mTOR. J. Biol. Chem. 272, 26457–26463 (1997).
  Article CAS Google Scholar
• Miron, M. et al. The translational inhibitor 4E-BP is an effector of PI(3)K/Akt signalling and cell growth in Drosophila. Nature Cell Biol. 3, 596–601 (2001).
  Article CAS Google Scholar
• Cross, D.A., Alessi, D.R., Cohen, P., Andjelkovich, M. & Hemmings, B.A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785–789 (1995).
  Article CAS Google Scholar
• Hinkle, R.T. et al. Skeletal muscle hypertrophy and anti-atrophy effects of clenbuterol are mediated by the β2-adrenergic receptor. Muscle Nerve 25, 729–734 (2002).
  Article CAS Google Scholar
• Crespo, P., Xu, N., Simonds, W.F. & Gutkind, J.S. Ras-dependent activation of MAP kinase pathway mediated by G-protein βg subunits. Nature 369, 418–420 (1994).
  Article CAS Google Scholar
• Lecker, S.H. et al. Ubiquitin conjugation by the N-end rule pathway and mRNAs for its components increase in muscles of diabetic rats. J. Clin. Invest. 104, 1411–1420 (1999).
  Article CAS Google Scholar
• Attaix, D., Combaret, L., Pouch, M.N. & Taillandier, D. Regulation of proteolysis. Curr. Opin. Clin. Nutr. Metab. Care 4, 45–9 (2001).
  Article CAS Google Scholar
• Gomes, M.D., Lecker, S.H., Jagoe, R.T., Navon, A. & Goldberg, A.L. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc. Natl Acad. Sci. USA 98, 14440–14445 (2001).
  Article CAS Google Scholar
• Bodine, S.C. et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294, 1704–1708 (2001).
  Article CAS Google Scholar
• Centner, T. et al. Identification of muscle specific ring finger proteins as potential regulators of the titin kinase domain. J. Mol. Biol. 306, 717–726 (2001).
  Article CAS Google Scholar
• McElhinny, A.S., Kakinuma, K., Sorimachi, H., Labeit, S. & Gregorio, C.C. Muscle-specific RING finger-1 interacts with titin to regulate sarcomeric M-line and thick filament structure and may have nuclear functions via its interaction with glucocorticoid modulatory element binding protein-1. J. Cell Biol. 157, 125–136 (2002).
  Article CAS Google Scholar